NOF_RK Consulting_1_bearbeitet-1

Selected publications:

On request we will be glad to send you a comprehensive list of publications.
Please click on title for direct PubMed access.

In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.
Sommerfeld MR, Müller G, Tschank G, Seipke G, Habermann P, Kurrle R, and Tennagels N.
PLoS One. (2010); Mar 4;5(3): e9540

ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs.
Randle JC, Harding MW, Ku G, Schönharting M, and Kurrle R.
Expert Opin Investig Drugs. (2001); Jul 10(7): 1207-9. Review

Combination therapy of malononitrilamides and tacrolimus (FK 506) induced
long-term xenograft survival.

Schorlemmer HU and Kurrle R.
Transplant Proc. (1998) Dec 30(8):4170-3.

Costimulation via TCR and IL-1 receptor reveals a novel IL-1alpha-mediated autocrine pathway
of Th2 cell proliferation.

Huber M, Beuscher HU, Rohwer P, Kurrle R, Röllinghoff M, and Lohoff M.
J Immunol. (1998) May 1;160(9):4242-7.

Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes.
Schulte T, Kurrle R, Röllinghoff M, and Gessner A.
J Exp Med. (1997) Nov 3;186(9):1419-29.

CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
Siefken R, Kurrle R, and Schwinzer R.
Cell Immunol. (1997) Feb 25;176(1):59-65.

Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones  with different T-helper phenotypes: role of CD95/CD95L interactions.
Accornero, P., M. Radrizzani, D. Delia, F. Gerosa, R. Kurrle, and M. P. Colombo
Blood (1997);89: 558-569..

alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term  survival of cardiac allografts after pretreatment with R73 mAb is  associated with upregulation of Th2-type cytokines.
Heidecke CD, Hancock WW, Westerholt S, Sewczik T, Jakobs F, Zantl N, Varzaru A, Siegling A,
Kurrle R, Deusch K, Volk HD, and Kupiec-Weglinski JW.
Transplantation. (1996) Mar 27;61(6):948-56.

Regulation of IL-1 activity by soluble IL-1 receptors.
Kurrle R, Lauffer L, Röder J, Kanzy EJ, Enssle KH, and Seiler FR.
Behring Inst Mitt. (1995) Jun;(96):45-57. Review

Clinical evaluation of induction immunosuppression with a murine IgG2b  monoclonal antibody
(BMA 031) directed toward the human alpha/beta-T  cell receptor.

Knight RJ, Kurrle R, McClain J, Racenberg J, Baghdahsarian V, Kerman R, Lewis R, van Buren CT,
and Kahan BD.
Transplantation. 1994 Jun 15;57(11):1581-8.

Construction, expression and characterization of humanized antibodies directed against the human alpha/beta T cell receptor.
Shearman CW, Pollock D, White G, Hehir K, Moore GP, Kanzy EJ, and Kurrle R.
J Immunol. 1991 Dec 15;147(12):4366-73.

Construction, expression, and biologic activity of murine/human chimeric antibodies  with specificity for the human alpha/beta T cell receptor. 
Shearman CW, Kanzy EJ, Lawrie DK, Li YW, Thammana P, Moore GP, and Kurrle R.
J Immunol. 1991 Feb 1;146(3):928-35.

BMA 031, a monoclonal antibody suited to identify the T-cell receptor alpha  beta/CD3 complex on viable human T lymphocytes
in normal and disease  states.

Borst J, van Dongen JJ, de Vries E, Comans-Bitter WM, van Tol MJ, Vossen JM, and Kurrle R.
Hum Immunol. (1990) Nov;29(3):175-88

Cluster Report: CD3,
In “Fourth International Workshop and Conference On Human Leukocyte Differentiation Antigens”,
 Vienna, (1989): 290-293,
Kurrle R.,

Selective stimulation of human T lymphocyte subsets by heteroconjugates of  antibodies to the T cell receptor and to subset-specific differentiation antigens.
Emmrich F, Rieber P, Kurrle R, and Eichmann K.
Eur J Immunol. (1988) Apr 18(4):645-8

Influenza virus-specific T cell-mediated cytotoxicity: integration of the virus  antigen into the target cell membrane is essential for target cell  formation.
Kurrle R, Wagner H, Röllinghoff M, and Rott R.
Eur J Immunol. (1979) Feb 9(2):107-11